Provided by Tiger Trade Technology Pte. Ltd.

MAIA Biotechnology Inc.

1.46
-0.0400-2.67%
Post-market: 1.43-0.0300-2.05%19:49 EDT
Volume:646.42K
Turnover:935.82K
Market Cap:85.64M
PE:-1.90
High:1.50
Open:1.45
Low:1.41
Close:1.50
52wk High:3.19
52wk Low:0.8700
Shares:58.66M
Float Shares:28.34M
Volume Ratio:1.01
T/O Rate:2.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7683
EPS(LYR):-1.0476
ROE:-2691.07%
ROA:-148.38%
PB:2055.27
PE(LYR):-1.39

Loading ...

Jul 12, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 11, 2023

Major Issues Report

Form 8-K - Current report
Jul 10, 2023

Major Issues Report

Form 8-K - Current report
Jul 01, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 20, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 09, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 30, 2023

Major Issues Report

Form 8-K - Current report
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 27, 2023

Major Issues Report

8-K - Current report
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 20, 2023

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Apr 20, 2023

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 20, 2023

Major Issues Report

8-K - Current report
Apr 18, 2023

Correspondence

Form CORRESP - Correspondence